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m’10584 SelectiveReductionofCardiacPainThreeholdinSyndromeX
V. Pasceri, A. Buffon, A.S. Montenero, A. Manzoli, G..Patti, F.Crea,
A. Maseri, G.A. Lanza. Catholic University Rorna, Italy
Previous studias have shown that patients (pts) with syndrome X (SX) have
an increased cardiac sensitivity to painful stimuli. However, it is not clear
whether this finding iacaused by an abnormal pain perception orismerelydue
to an enhanced tendency to repofl chest pain by SX pts, as a consequence
of primaty psychological disorders. We assessed cardiac sensitivity to pain
in 16 SX pts (51 + 6 years, 4 men) and 15 control pts (53 + 8 years, 5
men) undergoing electrophysiologic study, by performing right atrium and
right ventricle pacing with increasing intensity (1 to 10 mA), at a rate 5 beats
higher than patient’s heart rate. To exclude psychologic influence on pain
perception, a false (FP) and a true (TP) pacing were performed in a random
sequence, blinded to both patient and investigator. Nocontrol pts had pacing-
induced pain, while 50% of SX pts reported pain in atrium (P < 0.01) and 94%
in ventricle (P < 0.001). In atrium TP and FP resulted in a similar incidence
of chest pain (50Y0vs 69%, P = 0.37), while in the ventricle TP induced an
higher incidence of pain (94% vs50%, P -=0.05). Pain threshold and severity
were similar during TP and FP in atrium, while in the ventricle pain threshold
was lower and severity higher during TP.
Pein threshold(mA) Pain severity (1-10 scale)
TP FP P TP FP P
Atrium 7.2 & 3.5 6.6 + 3.2 0.42 3,4 * 3.7 3.7 & 3.2 0.87
Ventricle 3.7 l 3.0 7.9 & 2.8 <0.001 7.3 & 2.7 3.1 i 3.5 <0.001
In conclusion, although psychologic factors may influence the report of
cheat pain by SX pt.%a reduced threshold for cardiac pain is detectable in
response to electrical stimulation of right ventricle.
D10585 DiaatolicLeftVentricularFunctionin PatientsWithRefractoryAnginaPectorisAfterLow-Dose
IntermittentUrokinaseTherapy
C.M. Schannwell, F.G.Schoebel, B. Politz, R. Marx, S. Heggen, M. Schmitz,
M. Leschke, B.E. Strauer. C/irricof Carcfio/og~F/eirrricfrffeirre University
Dkseldort Germany
Low-dose intermittent urokinase therapy has been establishedasacombined
rheologic and thrombdytic approach for antiischemic treatment in patients
(pts) with end-stage coronary artery disease and refractory angina pecroris
(AP). The impact of this therapeutic approach on Ieftventricular (LV)diastolic
function as a parameter for myocardial ischamia has not been investigated
so far.
In 25 pts with refractory AP 500000 IU of urokinase were administered
intravenously three times a week a treatment period of 12 weeks (36 in-
jections). Pulsed-wave Doppler echocardiography es an useful tool for the
noninvasive assessment of LV diastolic function was performed and the fol-
lowing Doppler indices were obtained in all pts and 21 normal age-matched
control subjects: peak early diastolic flow velocity (VE); acceleration (AT)and
deceleration timas (DT) of flow velocity in earfy diastole; rates of acceleration
and deceleration of flow velocity in early diastole; peak late diastolic flow
velocity (VA)and isovolumatric relaxation time (IVRT). Pts with refractory AP
had a higher peak A velocity and a prolonged deceleration time. The WA
ratio and the E ares/A area ratio were significantly lower in pts with refractory
AP.After Iow-doae intermittent urokinase therapy diastolic parameters nearly
normalized.
vA [tis] WA ratio VTIENTIA DT [ins] IVRT [ins]
controls 0.48 1.5 2.51 193 82
before UK 0.68” 1.2* 1.87* 262* 117*
after UK 0.57” 1.5” 2.ot” 212- 97-
UK= urokinasetherapy: p c 0.01 vs controls;“p <0.01 vs before UK
Corrc/usion: Diastolic LV function is severly impaired in patients with
refractory AP. Antiischemic effectiveness of low-dose intermittent urokinase
therapy can be verified by improvad diastolic function.
11058-8] ~~~~gct0rsforAn9i09raPhicment0fCoronaf’Y
S.H. Wilson, D.S. Celermajer, A. Naksgomi, R.N. Wyndham, M. Janu,
S.6. Freedman. Depsfimerrts of Cwdio/cW Roya/Prince A/fred Hospita/
and Concord Hospital, Sydney, Australia
Most acute coronary eventa occur as a result of thrombosis at sites of minor
plaque. Therefore, the extent of non-obstructive corona~ artery disease
(CAD), rather than simply the number of savere stenoses, maybe clinically
relevant. We have recently developed and validatad a novel “extent score”
for CAD which measures the percent of the corona~ tree involved by non-
obstructive plaque as judged at coronary angiography. The aims of this
study were: (1) to determine the relationship between this extent score and
traditional risk factors, as well aa more recently described predictors of CAD:
Lp(a) and dense LDL; and (2) todetarmine which risk factors were associated
with extensive rather than severe (obstructive) CAD.
Five hundred patients (349 men, age 61 + 11 years) who presented for
elective coronary angiogrsphy were assessed for (a) the extent end severity
of CAD and (b) the preaence of risk factors for CAD. Mean extent score was
55/100 (interquartile range 32-60). The presence of diabetes (p < 0.001),
currant or former smoking (p < 0005) and history of hypertension (p <
0.001) were associated with CAD extent. In the 321 patiente with a severity
score of Oor 1, diabetes wae associated with a greater extent (56% V 42%,
p < 0.005). In the 150 patients with detailed lipid data, extent of CAD was
correlated independently with age (p < 0.005), male gender (p < 0.05),
presence of diabetes (p < 0.05), Lp(a) (p < 0.005) and LDL/HDL ratio (p <
0.01).
Therefore, high CAD extent scores are associated with traditional CAD
risk factors and Lp(a) levels. In subjects with O or 1 vassel disease, the
presence of diabetes is associated with worse extent scores and potentially
higher risk of acute coronary events.
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m1059142 CoronaryStentinginWomen:Earlyin-Hoepitel
andLong-TermClinicalOutcomes
R. Mehran, T.A. Bucher, A.J. Lsnsky, J.J. Popma, G.S. Mintz, M.K. Hong,
J.R. Laird, L.F. Satler, K.M. Kent, A.D. Pichard, N.V. Summers, e. Wang,
M.B. Leon. Washington Hospital Centec Washington, DC, USA
Although women have higher reported peri-procedural complications and
worse outcomes compared to men during balloon angioplasty (NHLBI Reg-
istty), the impact of corona~ stanting on acute procedural resulta and long
term clinical outcome has not been studied. We analyzed the initial and long
term clinical outcome of 1200 patients (838 men vs 364 women) who had
parcutsneous revascularization of native coronaty lesions with stenting. Le-
sions were matched for reference vessel size, minimal lumen diameter, %
diameter stenosis by qualitative angiography, and cross sectional narrowing
(plaque/arterial area) by intravascular ultrasound.
Female Male P
In-HospitalComplications:
Q-wave Ml (%) 1.3 0.4 0.049
Non Q-wava Ml (%) 14.7 11,2 0.961
Death + Ml + CABG (4A) 3.7 2.2 0.135
VascularComplications(%) 9,4 3.9 <0.0001
Follow-up:(> 6 months)
Death (%) 1,1 0.78
Q-wave Ml (%)
0.49s
1.2 0.90 0.641
TLR (“A) 11.2 ta7 0.139
Any Event (%) 22.7 21.6 0.690
Weconc/ude: Despite stenting, women continue to have somewhat worse
in-hospital clinical complications when compared to men, perhaps seconda~
to other confounding factors (ie. oldar age, more diabetes, smaller body
surface area). However, at follow-up, the lower clinical event rates obsenred
after stents are similar in both groups.
1059-143 EetrogenReplacementTherapytieaucesRepeat
Revascularizstioni PostMenopausalWomen
afterIntracoronsryStenting:A LongTerm
FollowUP
D. Singh, M.W. Liu, A. Mathur, C. Piamsonboon, S.S. lyer, J.M. Patfe.,
R. Sutor, L.S. Dean, W.A. Baxley, G.S. Roubin. Division of Cardiovascuk?r
Diesease, The University of Alabama at Birmingham, Birmingham, AL, USA
Estrogan replacement therapy has been shown to reduce coronary morbidity
and mortality in post menopausal women. Between June 1993 and March
1996two groups of post menopausal women, one receivingestrogen therapy
(69 patienta), and the other no estrogen (60 patients) undarwent success-
ful intrscoronary stenting. Among the two groupa, 62 out of 69 and 55 out
